Dental South China International Expo Observation | Gelen Technology Collaborates with South China Exhibition to Create "Medviewer Future Clinic" Experience ZoneIssuing time:2026-03-06 12:40
On March 4, 2026, during an interview at the Dental South China International Expo, Gelen Technology stated that this year's South China Exhibition, in collaboration with Gelen Technology, focused on creating the "Medviewer Future Clinic" experience zone. The exhibits included the world's first smart headset specifically designed for medical scenarios, interconnected with devices such as microscopes, Intraoral Scanning (IOS) systems, and navigation systems. By wearing AR glasses, visitors could seamlessly switch between multi-device information simply by turning their heads, experiencing efficient "never-leave-the-patient" diagnosis and treatment. Their new product, the LeViewer glasses, features the ability to overlay real-time data, such as from root canal length measurement motors, onto the view of a medical magnifier. Gelen Technology (Booth: Hall 20.1, P01): is a global, specialized medical technology company. Its product portfolio covers medical image head-mounted display processing workstations, scanning robots, visual surgical instruments, and medical wearable devices. The company is currently the only head-mounted system R&D enterprise in the medical field to have secured tens of millions in funding. It is also the world's first and only high-tech enterprise to achieve independent software and hardware development of medical augmented reality technology and possess a complete, proprietary product production line. *This content was gathered by DENTALGOODNEWS (Leading Dental Industry Media, DGN) special correspondent Zhao Shuang. Click here to visit DGN Global Edition for the latest industry updates anytime.
Article classification:
New Products
【GOODNEWS】 Content for industry reference only (based on public info & professional judgment); not for decision-making. Readers bear full responsibility for their own judgment and risks.
Copyright © This Platform. Unauthorized reproduction & commercial use prohibited.
Errata, contributions & cooperation: Contact customer service via WeChat:HDSW_001
|
✉️
Subscribe to Our
Newsletter
We curate important stories and exclusive insights, delivered straight to your inbox.
In-depth analysis · Exclusive content · Fast-moving news
|
